Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03119298Completed

Measuring Fear of Physical Activity in Patients With Heart Failure

Role: collaborator

NCT02898246Completed

Fear of Activity in Situations (FActS) - Study 2016

Role: collaborator

NCT02519088Completed

A New Approach to a Personalized Patient Blood Management Program (pPBM) in Total Hip Arthroplasty (THA)

Role: lead

NCT00434616Phase 2Unknown

Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia

Role: collaborator

All 4 trials loaded